KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 2 analysts with an average price target of $200.07. This is a potential upside of $199.36 (28078.87%) from yesterday's end of day stock price of $0.71.

Kala Pharmaceuticals's activity chart (see below) currently has 42 price targets and 64 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.85% with an average time for these price targets to be met of 92.56 days.

Highest price target for KALA is $35, Lowest price target is $33, average price target is $34.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 16-Sep-2025. First documented stock forecast 13-Aug-2017.

Currently out of the existing stock ratings of KALA, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$35

$33.69 (2571.76%)

$12

1 months 29 days ago
(16-Sep-2025)

7/15 (46.67%)

$17.53 (100.34%)

242

Buy

$33

$31.69 (2419.08%)

$15

2 months 4 days ago
(10-Sep-2025)

1/4 (25%)

$16 (94.12%)

93

Buy

$15

$13.69 (1045.04%)

$15

1 years 2 months 27 days ago
(18-Aug-2024)

2/3 (66.67%)

$8.72 (138.85%)

450

Buy

3 years 3 months ago
(14-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

$75

$73.69 (5625.19%)

3 years 7 months 16 days ago
(29-Mar-2022)

0/2 (0%)

$2 (2.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 92.56 days on average for the stock forecasts to be realized with a an average price target met ratio 21.85

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

YI CHEN

Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?

DAVID MARIS

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Yi Chen has 2 price targets and 2 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

David Maris with highest potential upside - $948.69

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?